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From the Institute of Obstetrics and Gynaecology, Hammersmith Hospital, London Drugs administered to the mother can affect the fetus by preventing implantation or by causing resorption of the embryo, abortion or intrauterine death. It is a sobering thought that the first of these mechanisms is dignified by the name 'contraception' and that the remainder have far less medicolegal and economic significance than the survival of a defective fetus after a less drastic chemical or physical insult (Law Commission, 1974) .
The general principles of teratogenesis in humans have recently been reviewed by Lewis (1974) . The majority of drugs are of molecular weight below 1000 and pass the placenta into the fetus. Their rate of transfer is enhanced by small molecular weight, lipophilic properties, and a high concentration of nonionized drug, not bound to plasma protein, in the maternal circulation. Drugs for which detoxication mechanisms, metabolic degradation or urinary excretion are deficient in the fetus are more likely to accumulate.
The extent and nature of a teratogenic effect depend on length of gestation. In general, agents administered before implantation either destroy the embryo or damage cells in the blastocyst which can be replaced by undifferentiated cells which retain totipotency. Maximum susceptibility in man is during organogenesis, from the first week after fertilization until the ninth week, that is, from three to 11 weeks after the last menstrual period. The same stimulus may produce a different anomaly at different stages of gestation, depending on which organs are in a critical stage of development. Some agents show a predilection for causing abnormalities in particular organ systems; sometimes this can be related to a high local tissue concentration or specific influence on a particular metabolic pathway but in other instances the mechanism is unknown. The genetic constitution of the embryo has a major influence on its response, and species differences are the primary hindrance to the screening of agents in animals for teratogenic potential and the interpretation of the relevance of the results to humans. Even in man, racial and familial predisposition to particular anomalies may influence the nature of a teratogenic response. Janerich et al (1974) found an increased proportion of mothers of such babies had discontinued oral contraceptives in the cycle immediately before conception, compared with control series. It is possible that this might be linked with the 'aging ovum' situation. Ovulation is often delayed in the first cycle and conception late in the cycle may be linked with congenital abnormalities (Cross, 1961; Iffy, 1963; Hertig, 1967) . Also, it is not surprising that neonatal jaundice has been reported to be associated with previous maternal use of oral contraceptives. The ease with which the maturity of a pregnancy may be underestimated and consequently labour inadvertently induced prematurely may be the factor responsible. The association has not been confirmed in subsequent better controlled studies (Gould et al, 1974 (Wilkins, 1960 ) that 19-nor-progestagens given in early pregnancy can give rise to a very minor degree of virilization in female fetuses. When this occurs it is usually just clitoral hypertrophy which resolves over the first year of life, but occasionally fusion of the labioscrotal folds requires division. More serious are the cluster of cases of adenocarcinoma of the vagina in teenage girls whose mothers had been given stilboestrol during pregnancy in the Boston area (Herbst et al, 1971 ). On the other hand, Kinlen et al (1974) were unable to pinpoint a single case amongst the 12000 patients they estimated had been given stilboestrol in Great Britain.
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The number of cases of fetal abnormality that could possibly be attributed to sex hormones is small and, in most instances, the case is unproven. Oral contraceptive failure or administration of an oral pregnancy test do not qualify as a 'substantial risk' under the Abortion Act. With the oral contraceptives the dose of hormones has now been reduced to a very low level. On the other hand there is no valid indication for using oral pregnancy tests, and there is no evidence that either stilboestrol or 19-norsteroids have any value in pregnancy maintenance (Hawkins, 1974) and their use should be abandoned. Only with a woman suffering from primary habitual abortion who has demonstrable progesterone deficiency is there any case at all for hormone supplements, and 17-hydroxyprogesterone, which has not been indicted, is the most appropriate agent.
Antiepileptic Treatment
It is now clear that phenytoin and related agents can cause folic acid deficiency in pregnancy and, probably in consequence, give rise to congenital ab-normalities in a small proportion of babies. In addition, there is a risk of fetal bleeding during the confinement and the newborn babies are susceptible to a sedative withdrawal syndrome. It is important that epileptic women should plan their pregnancies and should start taking folic acid supplements before they even conceive and continue throughout the pregnancy. This is in order that any necessary adjustment can be made to the dose of phenytoin and that adequate folic acid is available during implantation and organogenesis. Parenteral vitamin K should be given to the mother early in labour and the newborn closely supervised in a neonatal unit for three days after delivery.
With epileptics controlled on barbiturates, the main risk is that of sedative withdrawal in the newborn, which requires careful management (Desmond et al, 1972 (Stirrat and Beard, 1973) "Where no risk is indicated, an association with an overall increase in fetal abnormality has been suspected. 6 500 000 women have been treated with metronidazole and there has never been any suggestion of carcinogenicity. Over 2500 cases of women treated during pregnancy are reported in the medical literature and no atypical incidence of congenital abnormalities has been recorded. The major retrospective surveys have failed to suggest any teratogenic association. It must also be taken into account that vaginal trichomoniasis is commonly associated with in-situ and invasive carcinoma of the cervix, and that women with untreated trichomonal infections have a tendency to go into premature labour of the type that starts with rupture of the membranes.
The evidence on metronidazole should be considered against the background that when the drug was introduced as an oral agent in Great Britain 15 years ago, its efficacy was rapidly recognized and it swept the market of all the relatively ineffective local trichomonacides. The current criticisms have arisen in the United States of America within a year or two of the introduction of oral metronidazole to the American market.
In practice, avoidance of the use of oral metronidazole in pregnancy during the first 16 weeks should relieve any doubts about its potential, though the case is entirely unproven.
Barbiturates
Obstetricians have a justifiable scepticism about criticism of the use of barbiturates. The drugs have been enormously widely used during pregnancy for over 40 years, with much benefit to the patients. Fifteen years ago suspicions were voiced that the drugs caused liver damage in the newborn. Seven years ago we were advised that they stimulated formation of detoxifying enzymes in the fetal liver which tended to protect the baby against birth asphyxia and neonatal jaundice. Most recently (see British Medical Journal, 1972) we have been told of the possiblity of generating behavioural abnormalities in the babies. Although barbiturates are used so widely in pregnancy, the retrospective surveys are equivocal with regard to teratogenesis. The slightly increased incidence of abnormalities found by Nelson and Forfar (1971) may well be accounted for by the complications of pregnancy for which barbiturates were prescribed. Detailed analysis of the data obtained in the Royal College of General Practitioners' survey (1975) showed no suggestion of a cause-and-effect relationship between barbiturate therapy and congenital malformations.
It seems reasonable to continue to use barbiturates in pregnancy in conditions where they are indicated, and perhaps preferable to prescribing newer drugs about which less is known. The babies of patients given moderate or large doses of barbiturates-or, for that matter, diazepam-up to the confinement, should be observed for any signs of a sedative withdrawal syndrome (Desmond et al, 1972; Cree et al, 1973) .
Tranquillzers
A number of antihistamines and phenothiazines used in the treatment of morning sickness have been successively indicted and cleared of suspicion. The widely used drugs, promethazine and its theophylline conjugate, have not been seriously questioned. Cyclizine and diphenhydramine are still under review and should probably be avoided.
Though there is no clear evidence with respect to monamine oxidase inhibitors and tricyclic antidepressants, obstetricians do not like them and anaesthetists do not like them. The suspicion is there that the baby which has been subjected to them in the intrauterine environment is at risk, and most practitioners adopt a reactionary attitude when prescribing sedatives and tranquillizers for pregnant women.
Lysergic acid diethylamide can be teratogenic in experimental circumstances. Isolated cases of congenital abnormalities have been seen in women who take drugs during pregnancy. It is difficult to obtain reliable histories and these cases could well be due to other teratogenic factors. There is as yet no significant evidence with respect to the effects of cannabis smoking on the fetus.
Alcohol
Attention has recently been drawn to a syndrome in the newborn associated with alcoholism in pregnancy . Microcephaly, skull malformations and other anomalies can occur. More consistent are intrauterine growth retardation, infant growth retardation and delayed behavioural development. The babies of alcoholic mothers need careful observation and follow up.
Tobacco Smoking
Since the first demonstration by Simpson (1957) of a correlation between smoking in pregnancy and retarded intrauterine growth, a mass of evidence on this correlation has built up (U.S. Department of Health, Education and Welfare, 1973) . Comments made at the time (Hawkins, 1959) remain unanswered -no causal mechanism has yet been clearly demonstrated. It is quite clear that smoking in pregnancy is associated with small-for-dates babies, and there may be an association with premature labour and perhaps with an increased perinatal mortality, though the last has not been confirmed in large-scale American studies. What is often said, but is quite unproven, is that persuading women to stop smoking in pregnancy improves the prognosis. The work of Butler et al (1972) , who showed that women who reported ceasing to smoke after the fourth month had a normal prognosis for the baby, is really unhelpful. It is a retrospective survey, susceptible to biased recall. In addition, women who stop smoking in pregnancy of their own volition are a special group who are exhibiting a pica. Women who are persuaded to stop smoking in pregnancy are a totally different group. In a recently controlled prospective study conducted in three London teaching hospitals the usual association was confirmed but it was shown that those women who were persuaded to stop smoking did not achieve an improved prognosis (Donovan, J., personal communication, 1975) .
The situation therefore harks back to the original contention that there are a proportion of women who have in common the attributes that they smoke and that they produce small babies!
Radiographs and Ultrasound
The recent publicity given to the desirability of avoiding all but urgent radiological examinations during the second half of the menstrual cycle (Royal College of Radiologists, 1975) to avoid any risk to an early conceptus is obviously reasonable. Similarly the avoidance of non-essential radiographs in pregnancy, the precautions taken to minimize exposure and the avoidance of examinations involving multiple exposures are sound practice. On the other hand it must be recalled that the numerical risk to the fetus is extremely small. In these circumstances the fact that a woman has inadvertently had a radiological examination in early pregnancy cannot be taken to constitute the substantial risk of physical or mental abnormality in the baby which constitutes grounds for terminating the pregnancy under the Abortion Act.
Much play has been made in recent years of the idea that many radiological examinations in pregnancy could be replaced by the use of ultrasound. It should be borne in mind that whether or not ultrasound examinations can have teratogenic long-term effects on the fetus is quite unknown.
Conclusion
The practitioner who restricts his prescribing for pregnant women to circumstances where medication is really indicated, and employs medicines which have been widely used in pregnancy for many years without apparent harm is unlikely to contribute significantly to the incidence of congenital malformations.
